2-acetylaminofluorene has been researched along with paclitaxel in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Chung, JG; Hsia, TC; Lin, HJ; Yang, JH; Yu, CS; Yu, FS | 1 |
2 other study(ies) available for 2-acetylaminofluorene and paclitaxel
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Paclitaxel inhibits N-acetyltransferase activity and gene expression in human stomach tumor cells (SC-M1).
Topics: 2-Acetylaminofluorene; Antineoplastic Agents, Phytogenic; Arylamine N-Acetyltransferase; Carcinogens; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; DNA Adducts; Dose-Response Relationship, Drug; Gene Expression; Humans; Kinetics; Paclitaxel; RNA, Messenger; Stomach Neoplasms | 2004 |